3.82
price up icon5.52%   0.20
after-market アフターアワーズ: 3.82
loading
前日終値:
$3.62
開ける:
$3.57
24時間の取引高:
134.89K
Relative Volume:
0.15
時価総額:
$3.76M
収益:
-
当期純損益:
$-16.28M
株価収益率:
-5.8769
EPS:
-0.65
ネットキャッシュフロー:
$-13.75M
1週間 パフォーマンス:
-2.55%
1か月 パフォーマンス:
-28.46%
6か月 パフォーマンス:
-44.80%
1年 パフォーマンス:
-46.94%
1日の値動き範囲:
Value
$3.57
$4.35
1週間の範囲:
Value
$3.41
$4.35
52週間の値動き範囲:
Value
$3.40
$17.40

Pasithea Therapeutics Corp Stock (KTTA) Company Profile

Name
名前
Pasithea Therapeutics Corp
Name
セクター
Healthcare (1182)
Name
電話
(818) 422-6172
Name
住所
2110 NARCISSUS CT, VENICE
Name
職員
8
Name
Twitter
Name
次回の収益日
2024-08-11
Name
最新のSEC提出書
Name
KTTA's Discussions on Twitter

Pasithea Therapeutics Corp (KTTA) 最新ニュース

pulisher
Oct 26, 2024

KTTA stock touches 52-week low at $3.6 amid market challenges - Investing.com Australia

Oct 26, 2024
pulisher
Oct 25, 2024

KTTA stock touches 52-week low at $3.6 amid market challenges By Investing.com - Investing.com South Africa

Oct 25, 2024
pulisher
Oct 20, 2024

pasithea therapeutics corp Earnings dates - RTTNews

Oct 20, 2024
pulisher
Oct 07, 2024

(KTTA) Investment Analysis - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 02, 2024

Allogene Therapeutics (ALLO) Stock Drops Over 5% Amid Market Act - GuruFocus.com

Oct 02, 2024
pulisher
Sep 30, 2024

Was there any good news for Pasithea Therapeutics Corp (KTTA) stock in the last session? - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Allogene Therapeutics (ALLO) Stock Jumps by 5.15% - GuruFocus.com

Sep 27, 2024
pulisher
Sep 27, 2024

Market cap of Pasithea Therapeutics Corp [KTTA] reaches 6.08M – now what? - The DBT News

Sep 27, 2024
pulisher
Sep 27, 2024

PAS-004 Has Tolerable Safety Profile and Preliminary Efficacy in MAPK-Driven Solid Tumors - OncLive

Sep 27, 2024
pulisher
Sep 27, 2024

Pasithea Therapeutics Corp. (NASDAQ:KTTA) Stock Gains After Private Placement - DRP Journal

Sep 27, 2024
pulisher
Sep 27, 2024

Pasithea Therapeutics drops 19% on $5M private placement - MSN

Sep 27, 2024
pulisher
Sep 27, 2024

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer - Marketscreener.com

Sep 27, 2024
pulisher
Sep 27, 2024

Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times

Sep 27, 2024
pulisher
Sep 26, 2024

Grid Battery Metals Inc. (TSXV:CELL) (OTCQB:EVKRF) Stock Gains Momentum: Is It Sustainable? - DRP Journal

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics prices $5M at-the-market private placement at $4.10/share - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

Technical Explosions: DUO, KTTA, TBIO, GOTUWatch Peraso Inc. (NASDAQ: PRSO) Now Amid Breakout Momentum! - openPR

Sep 26, 2024
pulisher
Sep 26, 2024

Schwab Splitting Shares for Two-Thirds of ETF Lineup - Yahoo! Voices

Sep 26, 2024
pulisher
Sep 26, 2024

Biotech Stock Pasithea Therapeutics Corp. (NASDAQ: KTTA) Soars on Positive Data from Phase 1 Clinical Trials - Investorideas.com newswire

Sep 26, 2024
pulisher
Sep 26, 2024

Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga

Sep 26, 2024
pulisher
Sep 26, 2024

Stocks Stay Higher With Tech Still Driving Gains: Markets Wrap - Yahoo Finance

Sep 26, 2024
pulisher
Sep 26, 2024

Why XPeng Stock Spiked Higher Today - Yahoo! Voices

Sep 26, 2024
pulisher
Sep 26, 2024

Why Is Pasithea Therapeutics Stock Surging On Thursday? - AOL

Sep 26, 2024
pulisher
Sep 26, 2024

KTTA’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 26, 2024
pulisher
Sep 26, 2024

Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga

Sep 26, 2024
pulisher
Sep 26, 2024

English cricket ‘disconnected from reality’ in valuation of the Hundred - Yahoo! Voices

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics Shares Move Higher After Positive Data for Cancer Treatment - MarketWatch

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea reports positive early data on cancer drug PAS-004 - Investing.com India

Sep 26, 2024
pulisher
Sep 26, 2024

Visa agrees to buy AI-focused enterprise tech firm Featurespace - Yahoo! Voices

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics (KTTA) Sees Strong Pre-Market Gains - Stocks Telegraph

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics rises on positive early-stage data from cancer drug - XM

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics : Investor Presentation - Marketscreener.com

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), And Preliminary Efficacy Data From Its Phase 1 Clinical T... - MENAFN.COM

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics announces initial data from Phase 1 trial of PAS-004 - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics (KTTA) Reports Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from Phase 1 Trial of PAS-004 - StreetInsider.com

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics Announces Positive Initial Safety, - GlobeNewswire

Sep 26, 2024
pulisher
Sep 26, 2024

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer - StockTitan

Sep 26, 2024
pulisher
Sep 25, 2024

Factbox-OpenAI key personnel changes - Yahoo! Voices

Sep 25, 2024
pulisher
Sep 25, 2024

Why Viking Therapeutics Stock Was So Healthy on Wednesday - Yahoo Finance

Sep 25, 2024
pulisher
Sep 25, 2024

Pasithea Therapeutics Corp. announced that it expects to receive $5.000003 million in funding - Marketscreener.com

Sep 25, 2024
pulisher
Sep 25, 2024

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Sep 25, 2024
pulisher
Sep 25, 2024

Capstan Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance

Sep 25, 2024
pulisher
Sep 23, 2024

BDTX-1535 Generates Early Signals of Antitumor Activity in R/R EGFR+ NSCLC - OncLive

Sep 23, 2024
pulisher
Sep 21, 2024

The OncFive: Top Oncology Articles for the Week of 9/15 - OncLive

Sep 21, 2024
pulisher
Sep 20, 2024

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - Yahoo Finance

Sep 20, 2024
pulisher
Sep 19, 2024

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock? - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Pasithea Therapeutics (NASDAQ:KTTA) Trading Up 25.8% - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know - Yahoo Finance

Sep 18, 2024
pulisher
Sep 17, 2024

KTTAPasithea Therapeutics Corp. Latest Stock News & Market Updates - StockTitan

Sep 17, 2024
pulisher
Sep 17, 2024

Saghmos Therapeutics Announces Presentation at UBS 2024 Biotechnology Private Company Virtual Symposium - Yahoo Finance

Sep 17, 2024

Pasithea Therapeutics Corp (KTTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):